LDI and LDA use very dilute concentrations of antigens to help control an exaggerated immune response. An exaggerated immune response is felt to be largely responsible for any number of chronic diseases including auto-immune disease such as Rheumatoid Arthritis, Crohn’s disease, Interstitial Cystitis and Multiple Sclerosis as well as the long-term effects of infectious diseases such as chronic Lyme disease, Bartonella and molds. The difference between LDI and LDA is that LDI is used for infections while LDA is used for overactive immune responses to everyday exposures such as foods, chemicals and pollen. Exposure to any number of these agents can cause a person’s immune system to produce an exaggerated response leading to inflammation and a breakdown of body systems.
LDI and LDA are made up of very dilute concentrations of those offending agents. It is believed these dilutions promote the regulation of special immune cells called T regulator cells, restoring balance and calming an over-reactive immune system.
The key to LDI/LDA is finding the right concentration of agent to be used. We do this through A.R.T. testing. After the first dose, there are usually 3 possible outcomes: 1) improvement in symptoms for a short time, 2) worsening of symptoms for a short time and then a return to baseline or 3) no change in symptoms. Under scenario #1, the correct dose was given if the symptoms are controlled for up to 7 weeks and therefore subsequent doses will be given as frequently as biweekly as directed by your doctor. Under scenario #2, it is likely that the concentration was incorrect, and the dilution of the agent needs to be reduced. Under scenario #3, more doses may be needed before the patient will see improvement. Occasionally 2-3 doses must be given before the patient will start to see improvement.
It is very important for the patient to track symptoms simply. You will be asked if there was improvement in symptoms, an increase in symptoms or no change. The doctor will check your LDI’s at every visit. If you are given the LDI’s to take home, please return with them at each visit.
Risks for this treatment are extremely low. There is a possibility that symptoms might worsen for a short period of time.